Management of Indirect Neonatal Hyperbilirubinemia [Internet]

This guideline applies to the management of indirect hyperbilirubinemia in neonates less than 8 days of life and 35 weeks gestation or more. This guideline does not include the management of neonatal direct hyperbilirubinemia or hyperbilirubinemia in patients greater than 8 days of age. This guideline excludes premature neonates born prior to 35 weeks gestation. The objective of this guideline is to create an evidence-based standard for the management of neonates with indirect hyperbilirubinemia across all care settings (newborn nursery, intensive care units, general inpatient service, home care, primary care, and emergency department) that provides appropriate care to patients, reduces unnecessary diagnostic tests and interventions, and improves patient outcomes.